it is compounded in concentrations ranging from 20 mg/mL to 200 mg/mL across 1 mL, 25 mL, 5 mL, 10 mL and 30 mL multi-dose vials, allowing prescribers to match dose and vial size precisely to patient requirements
Because APP deposition is a very late event following injury, we assume that this APP deposition rather reflects injury of the first immune attack (day 1025), when treatment was not started yet
Please let your physician know if you have any pain, dizziness, shortness of breath, or muscle weakness after your treatment
405 Most patients with severe thalassemia experience complications of iron overload due to blood transfusions, which promote oxidative damage to various organs, leading to endocrine and ultimately organ dysfunction